TW200734344A - Antibacterial agents - Google Patents

Antibacterial agents

Info

Publication number
TW200734344A
TW200734344A TW095148255A TW95148255A TW200734344A TW 200734344 A TW200734344 A TW 200734344A TW 095148255 A TW095148255 A TW 095148255A TW 95148255 A TW95148255 A TW 95148255A TW 200734344 A TW200734344 A TW 200734344A
Authority
TW
Taiwan
Prior art keywords
compounds
antibacterial agents
methods
antibacterial
making
Prior art date
Application number
TW095148255A
Other languages
English (en)
Chinese (zh)
Inventor
Timothy Allen Johnson
Debra Ann Sherry
Dennis Joseph Mcnamara
Peter Laurence Toogood
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37872452&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=TW200734344(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of TW200734344A publication Critical patent/TW200734344A/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains four or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
TW095148255A 2005-12-22 2006-12-21 Antibacterial agents TW200734344A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US75326205P 2005-12-22 2005-12-22

Publications (1)

Publication Number Publication Date
TW200734344A true TW200734344A (en) 2007-09-16

Family

ID=37872452

Family Applications (1)

Application Number Title Priority Date Filing Date
TW095148255A TW200734344A (en) 2005-12-22 2006-12-21 Antibacterial agents

Country Status (12)

Country Link
US (2) US7557100B2 (enExample)
EP (2) EP2620439A1 (enExample)
JP (1) JP5513743B2 (enExample)
AR (1) AR058701A1 (enExample)
CA (1) CA2634644A1 (enExample)
DO (1) DOP2006000268A (enExample)
GT (1) GT200600520A (enExample)
NL (1) NL2000373C2 (enExample)
PE (1) PE20071137A1 (enExample)
TW (1) TW200734344A (enExample)
UY (1) UY30030A1 (enExample)
WO (1) WO2007072151A1 (enExample)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7601695B2 (en) 2003-03-10 2009-10-13 Optimer Pharmaceuticals, Inc. Antibacterial agents
DOP2006000268A (es) * 2005-12-22 2007-07-31 Pfizer Prod Inc Agentes antibacterianos
RU2010103101A (ru) * 2007-07-02 2011-08-10 Астразенека Аб (Se) Химические соединения
ATE523592T1 (de) * 2007-07-06 2011-09-15 Univ Aarhus Dehydratisierte chitosan-nanopartikel
US20110178064A1 (en) 2007-07-16 2011-07-21 Astrazeneca R&D Spiro condensed barbituric acid derivatives for use as antibacterial
AU2008316830B2 (en) 2007-10-25 2016-03-17 Cempra Pharmaceuticals, Inc. Process for the preparation of macrolide antibacterial agents
US9040528B2 (en) 2008-10-14 2015-05-26 Astrazeneca Ab Chemical compounds 542
TW201020258A (en) * 2008-10-14 2010-06-01 Astrazeneca Ab Chemical compounds 542
CN107854477A (zh) 2008-10-24 2018-03-30 森普拉制药公司 使用含三唑的大环内酯治疗抗性疾病的方法
US9937194B1 (en) 2009-06-12 2018-04-10 Cempra Pharmaceuticals, Inc. Compounds and methods for treating inflammatory diseases
US9480679B2 (en) 2009-09-10 2016-11-01 Cempra Pharmaceuticals, Inc. Methods for treating malaria, tuberculosis and MAC diseases
HRP20160168T1 (hr) 2010-03-22 2016-03-25 Cempra Pharmaceuticals Inc Kristalne forme makrolida i njihova uporaba
BR112012029586A2 (pt) 2010-05-20 2016-08-02 Cempra Pharmaceuticals Inc processos para preparar macrolídeos e cetolídeos e intermediários dos mesmos
KR20130120458A (ko) 2010-09-10 2013-11-04 셈프라 파마슈티컬스, 인크. 질환을 치료하기 위한 수소결합 형성 플루오로 케토라이드
WO2013148891A1 (en) 2012-03-27 2013-10-03 Cempra Pharmaceuticals, Inc. Parenteral formulations for administering macrolide antibiotics
US8952149B2 (en) 2012-09-26 2015-02-10 Zoetis Llc Tricyclic tetrahydroquinoline antibacterial agents
US8889671B2 (en) 2013-01-23 2014-11-18 Astrazeneca Ab Compounds and methods for treating bacterial infections
WO2014152326A1 (en) 2013-03-14 2014-09-25 Cempra Pharmaceuticals, Inc. Methods for treating respiratory diseases and formulations therefor
AU2014233240B2 (en) 2013-03-15 2018-08-09 Cempra Pharmaceuticals, Inc. Convergent processes for preparing macrolide antibacterial agents
SG11201609404SA (en) 2014-05-29 2016-12-29 Entasis Therapeutics Ltd Fused, spirocyclic heteroaromatic compounds for the treatment of bacterial infections
UY36851A (es) 2015-08-16 2017-03-31 Glaxosmithkline Ip Dev Ltd Compuestos para uso en aplicaciones antibacterianas
IL317854A (en) 2017-07-28 2025-02-01 Takeda Pharmaceuticals Co TYK2 inhibitors and their uses

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5011860A (en) * 1986-04-11 1991-04-30 Schering Corporation Aryl-substituted naphthyridine and pyridopyrazine derivatives and their use in treating hyperproliferative skin diseases
DE19502178A1 (de) * 1994-01-27 1995-08-03 Hoechst Ag Thiadiazolderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Vorprodukte zur Herstellung von Flüssigkristallen
US6608081B2 (en) * 1999-08-12 2003-08-19 Ortho-Mcneil Pharmaceutical, Inc. Bicyclic heterocyclic substituted phenyl oxazolidinone antibacterials, and related compositions and methods
CZ20031083A3 (cs) 2000-10-26 2004-03-17 Pfizer Products Inc. 5-Spiropyrimidin-2, 4, 6-trionové inhibitory metaloproteinasy
BR0210099A (pt) * 2001-05-30 2004-04-13 Warner Lambert Co Agentes antibacterianos
AU2003228701A1 (en) 2002-04-25 2003-11-10 Bristol-Myers Squibb Company Spirobarbituric acid derivatives useful as inhibitors of matrix metalloproteases
US7208490B2 (en) 2002-10-07 2007-04-24 Pharmacia & Upjohn Company Llc Tricyclic tetrahydroquinoline antibacterial agents
CA2606847A1 (en) 2005-05-09 2006-11-16 Warner-Lambert Company Llc Antibacterial agents
DOP2006000268A (es) * 2005-12-22 2007-07-31 Pfizer Prod Inc Agentes antibacterianos

Also Published As

Publication number Publication date
WO2007072151A1 (en) 2007-06-28
UY30030A1 (es) 2007-07-31
JP5513743B2 (ja) 2014-06-04
JP2009520804A (ja) 2009-05-28
US20090275536A1 (en) 2009-11-05
NL2000373A1 (nl) 2007-06-26
AR058701A1 (es) 2008-02-20
CA2634644A1 (en) 2007-06-28
US7557100B2 (en) 2009-07-07
NL2000373C2 (nl) 2010-02-02
US20070197518A1 (en) 2007-08-23
GT200600520A (es) 2007-07-17
EP1971612A1 (en) 2008-09-24
EP2620439A1 (en) 2013-07-31
PE20071137A1 (es) 2008-01-10
DOP2006000268A (es) 2007-07-31

Similar Documents

Publication Publication Date Title
TW200800967A (en) Benzimidazole thiophene compounds
MX2009000285A (es) Piperidinas sustituidas que incrementan la actividad de p53 y usos de las mismas.
MX347688B (es) Moleculas pequeñas que contienen boro.
MY139124A (en) Gyrase inhibitors and uses thereof
MX2009004707A (es) Piridina carboxamides como inhibidores 11-beta-hsd1.
DE602004021472D1 (en) Pyrimiidinverbindungen
UA95644C2 (ru) Пиридазиноновые производные, фармацевтическая композиция и способ лечения заболеваний
WO2007130655A3 (en) Phage derived antimicrobial activities
WO2008115281A3 (en) Compounds for treating viral infections
DE602004021644D1 (de) Gyraseinhibitoren und deren verwendungen
WO2006086562A3 (en) Phenylazetidinone derivatives
WO2007085852A3 (en) Antimicrobial materials
DOP2006000268A (es) Agentes antibacterianos
WO2007067559A3 (en) Antibacterial agents
TW200738659A (en) Novel compounds
IL178207A0 (en) Dalbavancin compositions for treatment of bacterial infections
WO2007089612A3 (en) Methods and compositions for treating and preventing bacterial infections
WO2006120563A3 (en) Antibacterial agents
CL2007001542A1 (es) Compuestos derivados de aminotiazoles, composicion farmaceutica; y uso para el tratamiento de infecciones bacterianas.
EP3939599A3 (en) Silicate containing compositions and methods of treatment
MXPA05008960A (es) Oxazolidinonas de indolona antibacteriales, intermedios para su preparacion y composiciones farmaceuticas que las contienen.
TW200716088A (en) Formulations and methods for treating amyloidosis
UY30629A1 (es) Nuevo péptido de actinomadura namibiensis
TW200738608A (en) Organic compounds
MX2009009074A (es) Macrolidos basados en eritromicina.